USP 797.org
  

 

  Q&A on USP 797  

USP 797 Home
How to Achieve USP 797 Compliance

JCAHO Schedule for USP 797 Implementation

Articles on USP 797

USP 797 2008 Guidelines

Purchase USP 797 Products

USP 797 Vendors

Q&A on USP 797

Contact Us

Questions and Answers on USP 797

Questions and Answers on USP 797: Answers Provided by Eric S. Kastango, MBA, RPh, FASHP:

  • E16 Question: Have you heard of any decision by NYS board of Pharmacy with regard to compliance with USP 797?
     
  • E16 Answer:  Based on conversations with Larry Mokhiber, Executive Director of the NYS Board of Pharmacy, the board can use USP standards (USP 797) to evaluate a pharmacist's or pharmacy's compliance in the event of a compounding incident.  There is nothing definitive planned in codifying the USP chapter into NYS laws and regulations that I am aware of at this time.

(Answer provided as a courtesy to usp797.org by Eric S. Kastango, MBA, RPh, FASHP. Please note that usp797.org is not responsible for this answer.)

  • About Eric S. Kastango: Since its inception, Eric S. Kastango has been at the forefront of USP <797>. He is an elected member of the United States Pharmacopoeia Sterile Compounding Committee (2005-2010). Over the years, he has held multiple American Society of Health-System Pharmacists chairmanships and committee positions. He was responsible for creating the “Comprehensive Sterile Compounding Compliance Gap Analysis and Risk Assessment Tool.” In this capacity, Mr. Kastango frequents pharmacy events as an expert speaker, contributes to industry journals, and teaches. Mr. Kastango received his Bachelor of Science in Pharmacy degree from the Massachusetts College of Pharmacy and Allied Health Sciences and a MBA from the University of Phoenix. Since 1980, he has practiced pharmacy in a number of practice settings (including hospitals, community, and home care) in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation, which has 72 pharmacies in 44 states. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation, and has made over 100 presentations on a variety of pharmacy practice topics.  Mr. Kastango is the President and CEO of Clinical IQ, and can be reached as follows:

Mr. Eric S. Kastango – President and CEO
Clinical IQ, LLC 
184 Columbia Turnpike, #282 
Florham Park, NJ  07932 
Tel: (973) 765-9393 --- www.clinicaliq.com

What you will find on USP797.org : USP 797 regulations USP 797 vendors USP 797 products USP 797 articles USP 797 cleanrooms USP 797 barrier isolators USP 797 software
© 2005 USP 797.org / 59 West 19th St. : New York, NY  10011 : (212-463-0800) : info@usp797.org